Acalabrutinib
Showing 126 - 137 of 137
Chronic Lymphocytic Leukemia Trial (Evaluation of response to treatment with response-tailored Ibrutinib in patients with
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Evaluation of response to treatment with response-tailored Ibrutinib in patients with chronic lymphocytic leukemia
- (no location specified)
Dec 27, 2022
Metastatic Pancreatic Cancer Trial in United States (ACP-196, Nab-paclitaxel, Gemcitabine)
Immune Thrombocytopenia, Treatment Trial in Tianjin (Zanubrutinib)
Recruiting
- Immune Thrombocytopenia
- Treatment
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Jan 19, 2022
A Disease Registry of Patients With Mantle Cell Lymphoma
Active, not recruiting
- Mantle Cell Lymphoma
-
Montgomery, Alabama
- +33 more
Oct 28, 2022
Acute Myeloid Leukemia, MDS Trial in United States (CG-806)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Duarte, California
- +9 more
Mar 4, 2022
Chronic Lymphoid Leukemia Trial in France (Ambulatory medical assistance)
Not yet recruiting
- Chronic Lymphoid Leukemia
- Ambulatory medical assistance
-
Saint Pierre, ILE DE LA Reunion, France
- +15 more
Jul 29, 2022
Rheumatoid Arthritis Trial in United States (acalabrutinib, Placebo)
Completed
- Rheumatoid Arthritis
- acalabrutinib
- Placebo
-
Anniston, Alabama
- +16 more
Mar 25, 2019
Quality of Life of Lymphomas Treated With Oral Therapy
Recruiting
- Quality of Life
- Questionnaire
-
Toulouse 9, FranceLoïc YSEBAERT
Apr 22, 2022
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Best Practice, Ibrutinib, Patient Derived
Unknown status
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Best Practice
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 23, 2020
Mantle Cell Lymphoma Trial (acalabrutinib, ibrutinib, rituximab)
Withdrawn
- Mantle Cell Lymphoma
- acalabrutinib
- +2 more
- (no location specified)
May 12, 2016